Abstract
Eight cases are reported of extensive retroperitoneal haemorrhage in patients receiving anticoagulant therapy who subsequently died and underwent postmortem examination. No patient had an obvious source of bleeding, and in 5 cases no other cause for death was apparent. Three patients had had vascular surgical procedures: the other 5 were given anticoagulants for suspected venous thrombo-embolism. Six cases presented as unexpected circulatory collapse with rapid demise. Four patients had in addition gastro-intestinal bleeding of varying degree, with no obvious source. This acute massive type of retroperitoneal bleeding contrasts with the commoner presentations of pain, swelling, bruising and compression neuropathy: a high index of suspicion and urgent treatment are required if mortality is to be reduced.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Basu D., Gallus A., Hirsh J., Cade J. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med. 1972 Aug 17;287(7):324–327. doi: 10.1056/NEJM197208172870703. [DOI] [PubMed] [Google Scholar]
- Bell W. R., Tomasulo P. A., Alving B. M., Duffy T. P. Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients. Ann Intern Med. 1976 Aug;85(2):155–160. doi: 10.7326/0003-4819-85-2-155. [DOI] [PubMed] [Google Scholar]
- Curry P. V., Bacon P. A. Retroperitoneal haemorrhage and neuropathy complicating anticoagulant therapy. Postgrad Med J. 1974 Jan;50(579):37–40. doi: 10.1136/pgmj.50.579.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DEWHURST F., POLLER L. ANTIHEPARIN ACTIVITY OF SOME HUMAN BLOOD PROTEIN FRACTIONS AND THEIR POSSIBLE RELATIONSHIP TO THROMBOSIS. J Clin Pathol. 1965 May;18:339–344. doi: 10.1136/jcp.18.3.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Flanc C., Kakkar V. V., Clarke M. B. The detection of venous thrombosis of the legs using 125-I-labelled fibrinogen. Br J Surg. 1968 Oct;55(10):742–747. doi: 10.1002/bjs.1800551007. [DOI] [PubMed] [Google Scholar]
- Mant M. J., O'Brien B. D., Thong K. L., Hammond G. W., Birtwhistle R. V., Grace M. G. Haemorrhagic complications of heparin therapy. Lancet. 1977 May 28;1(8022):1133–1135. doi: 10.1016/s0140-6736(77)92388-1. [DOI] [PubMed] [Google Scholar]
- O'Sullivan E. F., Hirsh J., McCarthy R. A., de Gruchy G. C. Heparin in the treatment of venous thrombo-embolic disease: administration, control and results. Med J Aust. 1968 Jul 27;2(4):153–159. doi: 10.5694/j.1326-5377.1968.tb29378.x. [DOI] [PubMed] [Google Scholar]